These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23067387)

  • 41. Carbonic anhydrase inhibitors. Interaction of the antiepileptic drug sulthiame with twelve mammalian isoforms: kinetic and X-ray crystallographic studies.
    Temperini C; Innocenti A; Mastrolorenzo A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4866-72. PubMed ID: 17588751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. X-ray crystallographic and kinetic investigations of 6-sulfamoyl-saccharin as a carbonic anhydrase inhibitor.
    Alterio V; Tanc M; Ivanova J; Zalubovskis R; Vozny I; Monti SM; Di Fiore A; De Simone G; Supuran CT
    Org Biomol Chem; 2015 Apr; 13(13):4064-9. PubMed ID: 25733161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carbonic anhydrases as targets for medicinal chemistry.
    Supuran CT; Scozzafava A
    Bioorg Med Chem; 2007 Jul; 15(13):4336-50. PubMed ID: 17475500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference.
    Temperini C; Cecchi A; Scozzafava A; Supuran CT
    Bioorg Med Chem; 2009 Feb; 17(3):1214-21. PubMed ID: 19119014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kinetic and X-ray crystallographic investigations of substituted 2-thio-6-oxo-1,6-dihydropyrimidine-benzenesulfonamides acting as carbonic anhydrase inhibitors.
    Vullo D; Supuran CT; Scozzafava A; De Simone G; Monti SM; Alterio V; Carta F
    Bioorg Med Chem; 2016 Aug; 24(16):3643-8. PubMed ID: 27316543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose-thioureido tails.
    Winum JY; Thiry A; Cheikh KE; Dogné JM; Montero JL; Vullo D; Scozzafava A; Masereel B; Supuran CT
    Bioorg Med Chem Lett; 2007 May; 17(10):2685-91. PubMed ID: 17376683
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aryl-4,5-dihydro-1
    Hargunani P; Tadge N; Ceruso M; Leitans J; Kazaks A; Tars K; Gratteri P; Supuran CT; Nocentini A; Toraskar MP
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283813
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Privileged scaffolds in medicinal chemistry: Studies on pyrazolo[1,5-a]pyrimidines on sulfonamide containing Carbonic Anhydrase inhibitors.
    Gumus A; Bozdag M; Angeli A; Peat TS; Carta F; Supuran CT; Selleri S
    Bioorg Med Chem Lett; 2021 Oct; 49():128309. PubMed ID: 34371130
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of human carbonic anhydrase isoforms I-XIV with sulfonamides incorporating fluorine and 1,3,5-triazine moieties.
    Ceruso M; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem; 2013 Nov; 21(22):6929-36. PubMed ID: 24103430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates?
    De Simone G; Scozzafava A; Supuran CT
    Chem Biol Drug Des; 2009 Sep; 74(3):317-21. PubMed ID: 19703035
    [TBL] [Abstract][Full Text] [Related]  

  • 51. (R)-/(S)-10-camphorsulfonyl-substituted aromatic/heterocyclic sulfonamides selectively inhibit mitochondrial over cytosolic carbonic anhydrases.
    Maresca A; Supuran CT
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1334-7. PubMed ID: 21300547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis of C-cinnamoyl glycosides and their inhibitory activity against mammalian carbonic anhydrases.
    Riafrecha LE; Rodríguez OM; Vullo D; Supuran CT; Colinas PA
    Bioorg Med Chem; 2013 Mar; 21(6):1489-94. PubMed ID: 23010455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis, structure-activity relationship studies, and X-ray crystallographic analysis of arylsulfonamides as potent carbonic anhydrase inhibitors.
    Gitto R; Damiano FM; Mader P; De Luca L; Ferro S; Supuran CT; Vullo D; Brynda J; Rezáčová P; Chimirri A
    J Med Chem; 2012 Apr; 55(8):3891-9. PubMed ID: 22443141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3170-3. PubMed ID: 19435663
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives.
    Brzozowski Z; Sławiński J; Gdaniec M; Innocenti A; Supuran CT
    Eur J Med Chem; 2011 Sep; 46(9):4403-10. PubMed ID: 21820216
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metronidazole-coumarin conjugates and 3-cyano-7-hydroxy-coumarin act as isoform-selective carbonic anhydrase inhibitors.
    Bonneau A; Maresca A; Winum JY; Supuran CT
    J Enzyme Inhib Med Chem; 2013 Apr; 28(2):397-401. PubMed ID: 22299576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition studies of new ureido-substituted sulfonamides incorporating a GABA moiety against human carbonic anhydrase isoforms I-XIV.
    Ceruso M; Antel S; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem; 2014 Dec; 22(24):6768-75. PubMed ID: 25468040
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of mammalian carbonic anhydrases I-XIV with grayanotoxin III: solution and in silico studies.
    Durdagi S; Scozzafava G; Vullo D; Sahin H; Kolayli S; Supuran CT
    J Enzyme Inhib Med Chem; 2014 Aug; 29(4):469-75. PubMed ID: 23914927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?
    Vullo D; Innocenti A; Nishimori I; Pastorek J; Scozzafava A; Pastoreková S; Supuran CT
    Bioorg Med Chem Lett; 2005 Feb; 15(4):963-9. PubMed ID: 15686894
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX.
    Thiry A; Ledecq M; Cecchi A; Dogné JM; Wouters J; Supuran CT; Masereel B
    J Med Chem; 2006 May; 49(9):2743-9. PubMed ID: 16640335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.